The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 14, 2016
Filed:
Mar. 12, 2015
Applicant:
Sanofi, Paris, FR;
Inventors:
Darshan Parikh, Bridgewater, NJ (US);
Praveen Raju, Bangalore, IN;
Assignee:
SANOFI, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); A61K 9/28 (2006.01); A61K 9/20 (2006.01); A61K 31/337 (2006.01); A61K 45/06 (2006.01); A61K 31/517 (2006.01); A61K 31/555 (2006.01);
U.S. Cl.
CPC ...
A61K 31/498 (2013.01); A61K 9/2009 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/286 (2013.01); A61K 9/2813 (2013.01); A61K 9/2866 (2013.01); A61K 31/337 (2013.01); A61K 31/517 (2013.01); A61K 31/555 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention is directed to compositions and methods that target the PI3K signaling pathway for the treatment or prevention of cancer. In one aspect, there is provided a pharmaceutical formulation comprising Polymorph E of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide.